Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas

Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of hepatocellular carcinoma, usually presenting in the younger population (<40 years) without underlying liver disease. Although it has a better prognosis than hepatocellular carcinoma, it has a high rate of recurrence months to ye...

Full description

Bibliographic Details
Main Authors: Nicolas A. Villa, Rahul Pannala, Douglas O. Faigel, Danielle J. Haakinson, Nitin Katariya, Ramesh Ramanathan, Dawn Jaroszewski, Thomas K. Lidner, Thomas Byrne
Format: Article
Language:English
Published: Karger Publishers 2015-07-01
Series:Case Reports in Gastroenterology
Subjects:
Online Access:http://www.karger.com/Article/FullText/437290
Description
Summary:Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of hepatocellular carcinoma, usually presenting in the younger population (<40 years) without underlying liver disease. Although it has a better prognosis than hepatocellular carcinoma, it has a high rate of recurrence months to years after primary resection. While sites of recurrence usually involve the liver, regional lymph nodes, peritoneum, and lung, metastasis to the pancreas is extremely rare, with only 2 other cases reported in the literature. We present the case of a 46-year-old patient with metastatic FL-HCC to the pancreas 30 years after diagnosis and 26 years since his last resected liver recurrence.
ISSN:1662-0631